Can low energy availability and related factors cause isolated low free T3?

Peripheral thyroid hormone conversion is a highly dynamic process regulated by nutritional, hormonal, and genetic factors. When these regulatory inputs are disrupted, individuals can present with isolated low free T3 (fT3) despite clinically normal TSH, free T4 (fT4), thyroid antibodies, and reverse T3 (rT3).

Mechanistic pathways of deiodination suppression

• Energy availability and HPA-axis activation: Low energy availability (LEA) acts as a primary metabolic stressor, directly downregulating peripheral deiodinase activity to conserve energy. Mechanistically, LEA triggers hypothalamic-pituitary-adrenal (HPA) axis strain, elevating cortisol levels. Elevated cortisol directly suppresses 5'-deiodinase activity, blocking the peripheral conversion of T4 to active T3.
• Cofactor and genetic limitations: Type II deiodinase relies on zinc as an essential cofactor; zinc deficiency directly impairs its enzymatic conversion capacity. Concurrently, genetic polymorphisms in the DIO1 gene (such as the rs2235544 allele) reduce baseline type 1 deiodinase expression and activity, lowering the systemic fT3/fT4 ratio.
• Vitamin D status: Though lower vitamin D levels correlate clinically with reduced active thyroid hormones, a direct molecular mechanism linking vitamin D status to peripheral T4-to-T3 deiodination kinetics remains less defined compared to zinc and cortisol pathways.

Clinical presentation and marker interactions

• Normal reverse T3 dynamics: While impaired T4-to-T3 conversion typically shunts pathway intermediates toward rT3, rT3 levels can remain within normal reference ranges. This occurs because certain low-activity DIO1 genetic variants simultaneously decrease both the peripheral generation of T3 and the clearance of rT3, or because the severity of the metabolic stressor is insufficient to spike systemic rT3.

Bottom line

• Low energy availability, HPA-axis strain, zinc deficiency, and DIO1 genetic variations can collectively impair peripheral deiodination, presenting clinically as isolated low free T3 with entirely normal TSH, free T4, thyroid antibodies, and reverse T3.